You Cheol Hwang (You-Cheol Hwang, Y-C Hwang)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 26

Top Topics

Randomized Controlled Trial

Cardiovascular Disease

Top Venues

Diabetes & metabolism journal

Hepatology communications

Diabetes, obesity & metabolism

European journal of preventive cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Ji Eun Jun, In-Kyung Jeong, Kyu Jeong Ahn, Ho Yeon Chung, You Cheol Hwang
Combination of low- or moderate-intensity statin and ezetimibe versus high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: A propensity-matched nationwide cohort study. European journal of preventive cardiology (2024)
Kyung Ah Han, You Cheol Hwang, Shin Je Moon, Ho Chan Cho, Hye Jin Yoo, Sung Hee Choi, Suk Chon, Kyoung-Ah Kim, Tae Nyun Kim, Jun Goo Kang, Cheol-Young Park, Jong Chul Won, Eunjoo Cho, Jeongyun Kim, Kyong-Soo Park
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study. Diabetes, obesity & metabolism (2024)
Ji Eun Jun, In-Kyung Jeong, Kyu Jeong Ahn, Ho Yeon Chung, You Cheol Hwang
Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study. European journal of preventive cardiology 31 (10) (2024)
So Young Park, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You Cheol Hwang
Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism 109 (7) (2024)
So Young Park, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You Cheol Hwang
Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism (2024)
Kyung Ah Han, You Cheol Hwang, Shin Je Moon, Ho Chan Cho, Hye Jin Yoo, Sung Hee Choi, Suk Chon, Kyoung-Ah Kim, Tae Nyun Kim, Jun Goo Kang, Cheol-Young Park, Jong Chul Won, Eunjoo Cho, Jeongyun Kim, Kyong-Soo Park
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study. Diabetes, obesity & metabolism 26 (9) (2024)
Yunjin J Yum, Jin Yoo, Kyuhoon Bang, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You Cheol Hwang
Peroxisome proliferator-activated receptor γ activation ameliorates liver fibrosis-differential action of transcription factor EB and autophagy on hepatocytes and stellate cells. Hepatology communications 7 (6) (2023)
Yunjin J Yum, Jin Yoo, Kyuhoon Bang, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You Cheol Hwang
Peroxisome proliferator-activated receptor γ activation ameliorates liver fibrosis-differential action of transcription factor EB and autophagy on hepatocytes and stellate cells. Hepatology communications 7 (6) (2023)
Yunjin J Yum, Jin Yoo, Kyuhoon Bang, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You Cheol Hwang
Peroxisome proliferator-activated receptor γ activation ameliorates liver fibrosis-differential action of transcription factor EB and autophagy on hepatocytes and stellate cells. Hepatology communications 7 (6) (2023)
You-Bin Lee, Gyuri Kim, Ji Eun Jun, Hyunjin Park, Woo Je Lee, You Cheol Hwang, Jae Hyeon Kim
An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial. Diabetes care (2023)
Yunjin J Yum, Jin Yoo, Kyuhoon Bang, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You Cheol Hwang
Peroxisome proliferator-activated receptor γ activation ameliorates liver fibrosis-differential action of transcription factor EB and autophagy on hepatocytes and stellate cells. Hepatology communications 7 (6) (2023)
Ji Eun Jun, So Young Park, In-Kyung Jeong, You Cheol Hwang, Kyu Jeong Ahn, Ho Yeon Chung
Delayed diagnosis of pseudohypoparathyroidism type 1a with rare hypothyroidism since childhood. Oxford medical case reports 2022 (8) (2022)
Ji Eun Jun, You Cheol Hwang, Kyu Jeong Ahn, Ho Yeon Chung, Se Young Choung, In-Kyung Jeong
The efficacy and safety of Dendropanax morbifera leaf extract on the metabolic syndrome: a 12-week, placebo controlled, double blind, and randomized controlled trial. Nutrition research and practice 16 (1) (2021)
You Cheol Hwang
Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582-9). Diabetes & metabolism journal 43 (6) (2020)
Sang Ouk Chin, You Cheol Hwang, In-Jin Cho, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung
Pancreatic fat accumulation is associated with decreased β-cell function and deterioration in glucose tolerance in Korean adults. Diabetes/metabolism research and reviews 37 (7) (2020)
You Cheol Hwang, Jae Hyeon Kim, Byung-Wan Lee, Woo Je Lee
A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor. Diabetes & metabolism journal 43 (6) (2019)
You Cheol Hwang, Hong-Yup Ahn, Cheol Young Park
Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study. Obesity (Silver Spring, Md.) 27 (8) (2019)
You Cheol Hwang, Se Won Kim, Kyu-Yeon Hur, Bong Soo Cha, In Joo Kim, Tae Sun Park, Sei Hyun Baik, Kun-Ho Yoon, Kwan-Woo Lee, In-Kyu Lee, Moon Kyu Lee
Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study. Journal of Korean medical science 34 (15) (2019)
Soo Heon Kwak, You Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang-Yong Kim, Jae Hyeon Kim
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study). Diabetes, obesity & metabolism 22 (2) (2019)
You Cheol Hwang, Ji Eun Jun, In Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus. Diabetes & metabolism journal 43 (5) (2019)
You Cheol Hwang, Wilfred Y Fujimoto, Steven E Kahn, Donna L Leonetti, Edward J Boyko
Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension. Diabetes & metabolism journal 43 (1) (2018)
You Cheol Hwang, I-J Cho, I-K Jeong, K J Ahn, H Y Chung
Factors associated with regression from prediabetes to normal glucose tolerance in a Korean general population: A community-based 10-year prospective cohort study. Diabetic medicine : a journal of the British Diabetic Association 35 (11) (2018)
You Cheol Hwang, Wilfred Y Fujimoto, Steven E Kahn, Donna L Leonetti, Edward J Boyko
Predictors of Incident Type 2 Diabetes Mellitus in Japanese Americans with Normal Fasting Glucose Level. Diabetes & metabolism journal 42 (3) (2018)
You Cheol Hwang, Wilfred Y Fujimoto, Steven E Kahn, Donna L Leonetti, Edward J Boyko
Predictors of Incident Type 2 Diabetes Mellitus in Japanese Americans with Normal Fasting Glucose Level. Diabetes & metabolism journal (2018)
Young Seok Song, You Cheol Hwang, Hong Yup Ahn, Cheol Young Park
Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans. Diabetes & metabolism journal 40 (4) (2016)
You Cheol Hwang
Hypoglycemia: Culprit or Bystander? Diabetes & metabolism journal 40 (3) (2016)